Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
13.86
-0.25 (-1.77%)
At close: May 30, 2025, 4:00 PM
13.69
-0.17 (-1.23%)
After-hours: May 30, 2025, 4:04 PM EDT

Sionna Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
16.3313.279.716.77
Research & Development
60.7457.2940.6334.61
Operating Expenses
77.0770.5650.3341.37
Operating Income
-77.07-70.56-50.33-41.37
Interest & Investment Income
10.048.172.771.13
Other Non Operating Income (Expenses)
0.710.70.3-
Pretax Income
-66.32-61.69-47.26-40.24
Net Income
-66.32-61.69-47.26-40.24
Net Income to Common
-66.32-61.69-47.26-40.24
Shares Outstanding (Basic)
10433
Shares Outstanding (Diluted)
10433
Shares Change (YoY)
277.77%31.56%13.80%-
EPS (Basic)
-6.81-15.99-16.11-15.61
EPS (Diluted)
-6.81-15.99-16.11-15.61
Free Cash Flow
-56.01-52.81-44.82-37.94
Free Cash Flow Per Share
-5.75-13.69-15.28-14.72
EBITDA
-76.41-69.89-49.75-41.25
D&A For EBITDA
0.660.670.580.12
EBIT
-77.07-70.56-50.33-41.37
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q